5T4-CXCR4 targeting cancer therapeutics (Cancer Research UK)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5T4-CXCR4 targeting cancer therapeutics (Cancer Research UK)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsTrophoblast glycoprotein modulators
TargetsTrophoblast glycoproteinC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A